<html xmlns:mso="urn:schemas-microsoft-com:office:office" xmlns:msdt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
<title></title>
<style type="text/css">
<!--
.Insert {  color: #339933; text-decoration: underline}
.Remove {  color: #FF0000; text-decoration: line-through}
-->
</style>

<!--[if gte mso 9]><xml>
<mso:CustomDocumentProperties>
<mso:BillNumber msdt:dt="string">596</mso:BillNumber>
<mso:BillSubject msdt:dt="string">Transparency in Health Care</mso:BillSubject>
<mso:BillFiledDate msdt:dt="string">2025-11-19T08:55:11Z</mso:BillFiledDate>
<mso:BillShortTitle msdt:dt="string">Defining the term âpersonal benefitâ; requiring health care practitioners to report any personal benefit received from a pharmaceutical company to the Department of Health; requiring the department to establish uniform reporting procedures and a publicly accessible online database for the reports; requiring the department to establish certain guidelines for health care practitioners, etc.</mso:BillShortTitle>
<mso:BillVersionName msdt:dt="string">Original Filed Version</mso:BillVersionName>
<mso:BillLegislativeSessionName msdt:dt="string">2026</mso:BillLegislativeSessionName>
<mso:BillChamber msdt:dt="string">S</mso:BillChamber>
<mso:BillEffectiveDate msdt:dt="string">2026-07-01T00:00:00Z</mso:BillEffectiveDate>
<mso:BillTypeAbbreviation msdt:dt="string">GB</mso:BillTypeAbbreviation>
<mso:BillTypeName msdt:dt="string">General Bill</mso:BillTypeName>
<mso:BillVersion msdt:dt="string">__</mso:BillVersion>
</mso:CustomDocumentProperties>
</xml><![endif]-->
</head>
<body>
<pre style="line-height: 1.5em; font-size: 12px">
       <b>Florida Senate</b> - <b>2026</b>                                     <b>SB 596</b><b></b>
       <b></b>
       
        
       <b>By </b>Senator Garcia
       
       
       
       
       
       36-00967-26                                            2026596__
    1                        A bill to be entitled                      
    2         An act relating to transparency in health care;
    3         creating s. 456.0525, F.S.; defining the term
    4         âpersonal benefitâ; requiring health care
    5         practitioners to report any personal benefit received
    6         from a pharmaceutical company to the Department of
    7         Health; requiring that such reports be updated at
    8         least quarterly and include certain information;
    9         requiring the department to establish uniform
   10         reporting procedures and a publicly accessible online
   11         database for the reports; providing requirements for
   12         the database; requiring the department to establish
   13         certain guidelines for health care practitioners;
   14         requiring the Auditor General to perform annual audits
   15         for specified purposes; providing for administrative
   16         and criminal penalties; providing an effective date.
   17          
   18  Be It Enacted by the Legislature of the State of Florida:
   19  
   20         Section 1.âSection 456.0525, Florida Statutes, is created
   21  to read:
   22         <u class="Insert">456.0525â</u><u class="Insert">Disclosure of personal benefits received from</u>
   23  <u class="Insert">pharmaceutical companies</u><u class="Insert">.â</u>
   24         <u class="Insert">(1)</u><u class="Insert">â</u><u class="Insert">As used in this section, the term</u><u class="Insert"> </u><u class="Insert">â</u><u class="Insert">p</u><u class="Insert">ersonal benefitâ</u>
   25  <u class="Insert">means any benefit or advantage, economic or noneconomic,</u>
   26  <u class="Insert">received outside of the context of a health care practitioner</u>
   27  <u class="Insert">patient relationship. The term includes, but is not limited to,</u>
   28  <u class="Insert">investment interests, gifts, financial incentives, kickback</u>
   29  <u class="Insert">fees, speaking fees, sponsored travel, research funding, free</u>
   30  <u class="Insert">samples, and any other form of compensation.</u>
   31         <u class="Insert">(2)</u><u class="Insert">â</u><u class="Insert">To promote transparency, accountability, and public</u>
   32  <u class="Insert">trust in health care in this state, each health care</u>
   33  <u class="Insert">practitioner shall report</u><u class="Insert"> to the department</u><u class="Insert"> any personal benefit</u>
   34  <u class="Insert">received from a pharmaceutical company. Reports must be updated</u>
   35  <u class="Insert">at least quarterly</u><u class="Insert"> and</u><u class="Insert"> </u><u class="Insert">include, at a minimum, </u><u class="Insert">details </u><u class="Insert">regarding</u>
   36  <u class="Insert">the nature, value, and purpose of </u><u class="Insert">any personal</u><u class="Insert"> benefit received.</u>
   37         <u class="Insert">(3)</u><u class="Insert">â</u><u class="Insert">The department shall </u><u class="Insert">establish</u><u class="Insert"> uniform reporting</u>
   38  <u class="Insert">procedures and a publicly accessible online database to maintain</u>
   39  <u class="Insert">the reports. The database must</u><u class="Insert"> allow</u><u class="Insert"> members of the public to</u>
   40  <u class="Insert">easily search by the name of a health care practitioner</u><u class="Insert"> or</u>
   41  <u class="Insert">pharmaceutical company and </u><u class="Insert">the </u><u class="Insert">type of </u><u class="Insert">personal benefit</u>
   42  <u class="Insert">received</u><u class="Insert">.</u>
   43         <u class="Insert">(</u><u class="Insert">4</u><u class="Insert">)</u><u class="Insert">â</u><u class="Insert">The department shall establish guidelines for health</u>
   44  <u class="Insert">care practitioners relating to ethical practices when engaging</u>
   45  <u class="Insert">with pharmaceutical companies.</u>
   46         <u class="Insert">(</u><u class="Insert">5</u><u class="Insert">)</u><u class="Insert">â</u><u class="Insert">The Auditor General shall perform annual audits to</u>
   47  <u class="Insert">monitor compliance with this section, verify the accuracy of</u>
   48  <u class="Insert">reported data, and address any conflicts of interest.</u>
   49         <u class="Insert">(</u><u class="Insert">6</u><u class="Insert">)âA violation of this section is grounds for disci</u><u class="Insert">plinary</u>
   50  <u class="Insert">action by the </u><u class="Insert">applicable</u><u class="Insert"> board. </u><u class="Insert">A second or subsequent </u><u class="Insert">violation</u>
   51  <u class="Insert">of this section constitute</u><u class="Insert">s</u><u class="Insert"> a misdemeanor of the first degree,</u>
   52  <u class="Insert">punishable as provided in s. 775.082 or s. 775.083.</u>
   53         Section 2.âThis act shall take effect July 1, 2026.

</pre>
</body>
</html>
